VitaDAO funds decentralized longevity research, which aligns with Eniola's CCT model for addiction and his independent, open-science approach. His preprints, Bayesian validation, and provisional patent demonstrate strong technical merit, though the DAO's focus on longevity may require framing addiction as a neurodegenerative/aging-related condition.